Joan Albert Barberà

About me

Featured publications

• β3-adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial

  Authors:

  García-Alvarez, A; Blanco, I; García-Lunar, I; Jordà, P; Rodriguez-Arias, JJ;

  (...)

  Delgado, JF; Mirabet, S; Fuster, V; Barberá, JA; Ibañez, B.

  See complete list of authors

  Reference: European Journal Of Heart Failure 2023.

• Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 years of evidence from the REHAP registry

  Authors:

  Salvador, ML; Rodríguez-Padial, L; Abánades, CS; Utrilla, AC; Mir, JAB;

  López-Meseguer, M; Cubero, JS; Samper, GJ; Vich, IB; Escribano-Subías, P.

  Reference: Journal Of Internal Medicine 2022.

• Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

  Authors:

  Humbert, M; Simonneau, G; Pittrow, D; Delcroix, M; Pepke-Zaba, J;

  (...)

  Snijder, RJ; Barberà, JA; Klotsche, J; Meier, C; Hoeper, MM.

  See complete list of authors

  Reference: Journal Of Heart And Lung Transplantation 2022.

• The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension

  Authors:

  Newnham M; South K; Bleda M; Auger WR; Barberà JA;

  (...)

  Pepke-Zaba J; Laffan M; Lane DA; Morrell NW; Toshner M .

  See complete list of authors

  Reference: European Respiratory Journal 2019.

• ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension

  Authors:

  Grünig E; Eichstaedt C; Barberà JA; Benjamin N; Blanco I;

  (...)

  Saxer S; Tulloh RM; Ulrich S; Vonk Noordegraaf A; Peacock AJ .

  See complete list of authors

  Reference: European Respiratory Journal 2019.

• Pulmonary hypertension in chronic lung disease and hypoxia

  Authors:

  Nathan SD; Barbera JA; Gaine SP; Harari S; Martinez FJ;

  (...)

  Peacock AJ; Pepke-Zaba J; Provencher S; Weissmann N; Seeger W.

  See complete list of authors

  Reference: European Respiratory Journal 2019.

• Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: Highlights from basic research to therapy.

  Authors:

  Huertas A; Guignabert C; Barberà JA; Bärtsch P; Bhattacharya J;

  (...)

  Vassilakopoulos T; Sanchez O; Savale L; Testa U; Wilkins MR.

  See complete list of authors

  Reference: European Respiratory Journal 2018.

• An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

  Authors:

  Kovacs G; Herve P; Barbera JA; Chaouat A; Chemla D;

  (...)

  Saggar R; Ulrich S; Vizza D; Vonk Noordegraaf A; Olschewski H .

  See complete list of authors

  Reference: European Respiratory Journal 2017.

• Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study

  Authors:

  Hoeper, Marius M.; McLaughlin, Vallerie V.; Albert Barbera, Joan; Frost, Adaani E.; Ghofrani, Hossein-Ardeschir;

  (...)

  Langley, Jonathan; Harris, Julia H. N.; Blair, Christiana; Rubin, Lewis J.; Vachiery, Jean-Luc;.

  See complete list of authors

  Reference: Lancet Respiratory Medicine 2016.

• Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry

  Authors:

  Delcroix M; Lang I; Pepke-Zaba J; Jansa P; D'Armini AM;

  (...)

  Jenkins D; Lindner J; Dartevelle P; Mayer E; Simonneau G .

  See complete list of authors

  Reference: Circulation 2016.

Featured Projects

• Knowledge for Improving Indoor Air Quality and Health (K-Health in Air - KHiA)

  Principal investigator: Joan Albert Barbera Mir

  Funder: Institut d'Investigacions Biomèdiques August Pi i Sunyer (Entidad de origen); Mecanismes fisiopatològics de les malalties respiratòries. Institut d'Investigacions Biomèdiques August Pi i Sunyer (Investigador principal (ip)); European Union

  Code: 101057693

  Duration: 01/09/2022 - 31/08/2026

• Análisis transcriptómico de células endoteliales en la hipertensión arterial pulmonar para identificar firmas de genes relacionados con la enfermedad y cambios moleculares inducidos por el tratamiento

  Principal investigator: Joan Albert Barbera Mir

  Funder: Instituto de Salud Carlos III

  Code: PI21/00403

  Duration: 01/01/2022 - 31/12/2024

• Caracterización fenotípica de la hipertensión pulmonar en las enfermedades respiratorias

  Principal investigator: Joan Albert Barbera Mir

  Funder: Instituto de Salud Carlos III

  Duration: 01/01/2019 - 31/12/2021

• Recerca traslacional en malalties pulmonars

  Principal investigator: Joan Albert Barberà

  Funder: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Agència de Gestió d’Ajuts Universitaris i de Recerca

  Duration: 01/03/2018 - 28/02/2021

• MoGlyNet. Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study

  Principal investigator: Joan Albert Barberà

  Funder: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Unión Europea

  Duration: 15/09/2015 - 31/12/2019